Timothy Spicer

4.7k citations

130 papers · 3.3k indexed · 1 hit paper · h-index 32

Impact in

Virology top 1%
- HIV Research and Treatment
Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 8
- HIV Research and Treatment 8
Molecular Medicine 7
- Antibiotic Resistance in Bacteria 7

Co-authors: Louis Scampavia Peter Hodder Franck Madoux Hugh Rosen Virneliz Fernández-Vega Benjamin F. Cravatt Peter Chase Thomas D. Bannister
Journals: SLAS DISCOVERY (35 papers)Assay and Drug Development Technologies (9 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Proceedings of the National Academy of Sciences (4 papers)ACS Chemical Biology (4 papers)
Partner nations: United States Australia Germany

In The Last Decade

Timothy Spicer

124 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

LPCAT3 Inhibitors Remodel the Polyunsaturated Phospholipid Content of Human Cells and Protect from Ferroptosis 2022 · 105 citations

Peers

Countries citing papers authored by Timothy Spicer

Since Specialization

Citations

This map shows the geographic impact of Timothy Spicer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Spicer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Spicer more than expected).

Fields of papers citing papers by Timothy Spicer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Spicer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Spicer. The network helps show where Timothy Spicer may publish in the future.

Co-authors

The 25 scholars most cited alongside Timothy Spicer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Timothy Spicer Line = papers co-authored together Timothy Spicer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multimodal Treatment of a Peripheral Primitive Neuroectodermal Tumor Originating From the Thoracic Cavity in a Dog Journal of Veterinary Internal Medicine ·庞春蕾, Kotesheva Aa, Mengting Chen, Sung-Hun Hwang, Timothy Spicer, Seul-Gi Cho, Henryk Ciurej, Muhammad Fayez Sahib, Enrico Consonni, Susan Mcdevitt, Paulo Vilar Saavedra, Audress Johnson, Bikash Sahay, G. Chuan, Shelby Koos, Marc E. Salute, Yongzhong Wen, ゆり立原, Rowan J. Milner	2025	0
2	High throughput screening for SARS-CoV-2 helicase inhibitors SLAS DISCOVERY ·Yuka Otsuka, Eunjung Kim, Hiromi Otsuka, John D. Carl, Chao Wang, Jesús María Aguirre, Sultan Ullah, HaJeung Park, Louis Scampavia, Thomas D. Bannister, Donghoon Chung, Timothy Spicer	2024	3
3	High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-2 SLAS DISCOVERY ·Emery Smith, Meredith E. Davis-Gardner, Rubén D. Garcia-Ordoñez, Webb-Robertson Bobbie-Jo, Mitchell Hull, Emily Chen, Xuerong Yu, Thomas D. Bannister, Pierre Baillargeon, Louis Scampavia, Patrick R. Griffin, Michael Farzan, Timothy Spicer	2023	13
4	Neutral ceramidase-active site inhibitor chemotypes and binding modes Bioorganic Chemistry ·Nicolas Coant, John D. Bickel, Ronald J. Rahaim, Yuka Otsuka, G. Linscott, Ruijuan Xu, Jéssica Edith Mendoza Montoya, Claudielle Pavão da Silva, Cungui Mao, Essa M. Saied, Christoph Arenz, Timothy Spicer, Thomas D. Bannister, Peter J. Tonge, Michael V. Airola, Louis Scampavia, Yusuf A. Hannun, Robert C. Rizzo, John D. Haley	2023	1
5	In Vitro and In Vivo Drug-Response Profiling Using Patient-Derived High-Grade Glioma Cancers ·中森孝雄, Virneliz Fernández-Vega, Jantzen Sperry, Jonathan Nakashima, Long Do, W. Andrews, Simina M. Boca, Derick A. Anglin, Sajeel Chowdhary, Denise Junger, Glauco R. Souza, Louis Scampavia, Khalid A. Hanafy, Frank D. Vrionis, Timothy Spicer	2023	7
6	Small-molecule inhibitor targeting orphan nuclear receptor COUP-TFII for prostate cancer treatment Science Advances ·Khaled Alghaashamy, Melissa Hostetler, Jun Qin, Mafei Xu, Tang Lidon, Jingjing Shi, Erli You, Louise Aggerstrøm Hansen, Maria Luisa Rigoletto Penteado, Peter Chase, Louis Scampavia, Franck Madoux, Timothy Spicer, Peter Hodder, H. Eric Xu, Sophia Y. Tsai, Ming‐Jer Tsai	2020	23
7	Identification of Novel, Structurally Diverse, Small Molecule Modulators of GPR119 Assay and Drug Development Technologies ·Ainhoa Nieto, Virneliz Fernández-Vega, Timothy Spicer, Emmanuel Sturchler, Subhan Hidayatullah, Nicole Kennedy, E. Glinskaya, Peter Chase, Louis Scampavia, Thomas D. Bannister, Peter Hodder, Patricia McDonald	2018	5
8	A High-Throughput Time-Resolved Fluorescence Energy Transfer Assay to Screen for Modulators of RGS7/Gβ5/R7BP Complex Assay and Drug Development Technologies ·Brian S. Muntean, Dipak N. Patil, Franck Madoux, James Fossetta, Louis Scampavia, Timothy Spicer, Kirill A. Martemyanov	2018	3
9	A Homogeneous Cell-Based Halide-Sensitive Yellow Fluorescence Protein Assay to Identify Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Ion Channel Assay and Drug Development Technologies ·Emery Smith, Kenneth A. Giuliano, John D. Carl, Pierre Baillargeon, Beate Probst-Wiemuth, Matthew D. Cullen, John P. Miller, AYFER ERDOĞAN ŞAFAK, Louis Scampavia, Timothy Spicer	2017	7
10	Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation eLife ·Lars Plate, Christina B. Cooley, John J. Chen, Ryan J Paxman, Ciara M Gallagher, Franck Madoux, Joseph C. Genereux, Σταυρούλα Λάλου, Dan Garza, Timothy Spicer, Louis Scampavia, Steven J Brown, Hugh Rosen, Evan T. Powers, Peter Walter, Peter Hodder, R. Luke Wiseman, Jeffery W. Kelly	2016	173
11	Development of a Phenotypic High-Content Assay to Identify Pharmacoperone Drugs for the Treatment of Primary Hyperoxaluria Type 1 by High-Throughput Screening Assay and Drug Development Technologies ·Franck Madoux, Jo Ann Janovick, David C. Smithson, Sonia Fargue, Christopher J. Danpure, Louis Scampavia, С. Г. Михайлов, Timothy Spicer, P. Michael Conn	2015	17
12	An Automated Miniaturized Method to Perform and Analyze Antimicrobial Drug Synergy Assays Assay and Drug Development Technologies ·Peter Chase, Revi Mariska, Franck Madoux, Eric Bishop, 章子奥津, Louis Scampavia, Timothy Spicer	2015	3
13	Development of an HTS-Compatible Assay for the Discovery of ASK1 Signalosome Inhibitors Using AlphaScreen Technology Assay and Drug Development Technologies ·Emmanuel Sturchler, Wei‐Min Chen, Timothy Spicer, Peter Hodder, Patricia McDonald, Derek R. Duckett	2014	2
14	High-Throughput Screening for Small Molecule Modulators of Motor Protein Kinesin Assay and Drug Development Technologies ·Beena M. Kadakkuzha, Timothy Spicer, Peter Chase, Hao Yu, Peter Hodder, Sathyanarayanan V. Puthanveettil	2014	4
15	A Phenotypic High Throughput Screening Assay for the Identification of Pharmacoperones for the Gonadotropin Releasing Hormone Receptor Assay and Drug Development Technologies ·P. Michael Conn, Emery Smith, Timothy Spicer, Peter Chase, Louis Scampavia, Jo Ann Janovick	2014	13
16	Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors Proceedings of the National Academy of Sciences ·Daniel A. Bachovchin, Justin T. Mohr, Anna E Speers, Chu Wang, Jacob M. Berlin, Timothy Spicer, Virneliz Fernández-Vega, Peter Chase, Peter Hodder, Stephan C. Schürer, Daniel K. Nomura, Hugh Rosen, Gregory C. Fu, Benjamin F. Cravatt	2011	87
17	Identification of Small-Molecule Inhibitors of the Colorectal Cancer Oncogene Krüppel-like Factor 5 Expression by Ultrahigh-Throughput Screening Molecular Cancer Therapeutics ·Agnieszka B. Bialkowska, Melissa Crisp, Thomas D. Bannister, Yuanjun He, Sarwat Chowdhury, Stephan C. Schürer, Peter Chase, Timothy Spicer, Franck Madoux, Chenlu Tian, Peter Hodder, Daniel Zaharevitz, Vincent W. Yang	2011	37
18	A Time-Resolved Fluorescence–Resonance Energy Transfer Assay for Identifying Inhibitors of Hepatitis C Virus Core Dimerization Assay and Drug Development Technologies ·Smitha Kota, Louis Scampavia, Timothy Spicer, Aaron B. Beeler, Virginia Takahashi, John K. Snyder, John A. Porco, Peter Hodder, A. Donny Strosberg	2009	21
19	A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding Proceedings of the National Academy of Sciences ·Pin‐Fang Lin, Wade Blair, Tao Wang, Timothy Spicer, Qi Guo, Nannan Zhou, Yi-Fei Gong, Manuela F. Silva, Ronald E. Rose, Gregory Yamanaka, Brett S. Robinson, Changben Li, Robert A. Fridell, Carol Deminie, G W Demers, Zheng Yang, Lisa Zadjura, Nicholas A. Meanwell, Richard J. Colonno	2003	285
20	Reverse Transcription Takes Place within Extracellular HIV-1 Virions: Potential Biological Significance AIDS Research and Human Retroviruses ·Hui Zhang, Ying Zhang, Timothy Spicer, Lynn Abbott, Yifei Deng, Bernard J. Poiesz	1993	81

About Timothy Spicer

Timothy Spicer is a scholar working on Virology, Molecular Medicine, Biophysics, Molecular Biology and Infectious Diseases, having authored 130 papers that have together received 3.3k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (20 papers), Peptidase Inhibition and Analysis (12 papers), Click Chemistry and Applications (9 papers), 3D Printing in Biomedical Research (9 papers), HIV Research and Treatment (8 papers), Antibiotic Resistance in Bacteria (7 papers), Cancer Cells and Metastasis (7 papers) and Protein Kinase Regulation and GTPase Signaling (7 papers). The work is most often cited by research in Virology (496 citations), Infectious Diseases (631 citations), Molecular Medicine (117 citations), Cell Biology (372 citations) and Molecular Biology (1.5k citations). Timothy Spicer has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Louis Scampavia, Peter Hodder, Franck Madoux, Hugh Rosen, Virneliz Fernández-Vega, Benjamin F. Cravatt, Peter Chase, Thomas D. Bannister, Dmitriy Minond and Steven J Brown. Their work appears in journals such as SLAS DISCOVERY, Assay and Drug Development Technologies, Bioorganic & Medicinal Chemistry Letters, Proceedings of the National Academy of Sciences and ACS Chemical Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact